The large majority (10/13) of these genes were reported to play a role in the regulation of estrogen and/or progesterone response in human breast cancer (NCOA7: [29]; NCOA3: [30]; USP22: [31]; MED24: [32]; CCAR1: [33]; CRY2: [34]; STAT5B: [35]; PAGR1: [36]; TAF1: [37]; PHB2: [38]). This evidence concerns the gene USP22 and breast carcinoma.